Skip to content

Unilever Global Change location

Unilever to acquire majority stake in Nutrafol

London – Unilever announced today that it has signed an agreement to acquire a majority stake in Nutrafol, a leading provider of hair wellness products. Unilever currently holds a minority stake (13.2%) in Nutrafol through Unilever Ventures.

A range of Nutrafol products. The number 1 dermatologist recommended hair growth brand in the US.

Nutrafol is the #1 dermatologist recommended hair growth brand in the U.S.1 , and offers a range of clinically tested, physician-formulated products designed to address thinning hair and compromised hair health for women and men, at various life stages. Unlike traditional hair growth products that focus on a singular cause, Nutrafol takes an individualised whole-body approach that leverages its patented Synergen Complex® - a blend of medical-grade nutraceutical ingredients that target multiple root causes affecting hair health including hormones, stress, lifestyle, metabolism, nutrition, and aging.

More than 114 million U.S. consumers experience hair health issues, which is cited as a top beauty concern for both women and men. As a result of its sophisticated in-house digital capabilities and scalable technology, Nutrafol is well positioned to build on its eCommerce success and to grow its multichannel presence, including the network of more than 3,000 physicians who sell its products. With the majority of its revenue coming from a loyal customer base, Nutrafol is poised for sustainable, scalable, and profitable growth.

Fernando Fernandez, President, Beauty and Wellbeing for Unilever said: “I am delighted to welcome Nutrafol to the Unilever family. Nutrafol and its holistic approach to hair health is the perfect complement to our growing portfolio of innovative wellness and supplements brands. I am confident that with the full support of Unilever behind Nutrafol, Giorgos and the team will continue to take this fast-growing business to even greater heights.”

Giorgos Tsetis, Co-Founder and CEO of Nutrafol, said: “Joining forces with a leading global organization like Unilever, and all the resources and scale that comes with that, is the natural evolution in our mission to help people grow into their best selves through wholebody health. I am so thankful to the Nutrafol team for all we have accomplished together. The Unilever family will be a great home for us as we continue to move the industry forward with new innovations to support the needs of consumers at every point of their hair health journey.”

Roland Peralta, Co-founder, Chief Innovation and Product Officer of Nutrafol said, “When we founded Nutrafol in 2016 it was inspired by our own experiences with thinning hair and the inability to find a natural, yet efficacious way to take control of our hair health. Nutrafol couldn’t be just another untested alternative to hair drugs and vitamins. Now we are proud to offer a suite of best-in-class, clinically backed products that help customers easily navigate and take control of their individualized hair needs.”

Nutrafol, backed by consumer-focused private equity firm L Catterton,will continue to be based in New York and led by CEO Giorgos Tsetis. Nutrafol will operate as part of Unilever’s Health & Wellbeing unit, which includes brands like OLLY, Liquid I.V. and Onnit. 2 Terms of the deal were not disclosed. The acquisition is subject to regulatory approval and customary closing conditions.

Media Contacts

Unilever Media Relations

About Nutrafol

As the #1 dermatologist-recommended hair growth supplement brand in the U.S.1 , Nutrafol is setting a new scientific standard for hair wellness through an individualized, whole-body approach. With a new caliber of clinically effective, premium products, Nutrafol addresses the internal root causes as the foundation of hair growth with additional hair health support at the scalp and through targeted boosters. Nutrafol’s team of doctors and researchers are constantly investing in scientific research and developments at the forefront of genetics, biotechnology, and anti-aging medicine to remain on the cutting-edge of hair health innovation. Nutrafol is backed by more than 3,000+ physicians across the U.S. for its trusted, reliable results, and has received numerous prestigious accolades.

Safe Harbour

Where relevant, these actions are subject to the appropriate consultations and approvals.

This document may contain forward-looking statements, including ‘forward-looking statements’ within the meaning of the United States Private Securities Litigation Reform Act of 1995. Words such as ‘will’, ‘aim’, ‘expects’, ‘anticipates’, ‘intends’, ‘looks’, ‘believes’, ‘vision’, or the negative of these terms and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. Forward-looking statements also include, but are not limited to, statements and information regarding the Unilever Group’s (the ‘Group’) emissions reduction targets and other climate change related matters (including actions, potential impacts and risks associated therewith). These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Group. They are not historical facts, nor are they guarantees of future performance or outcomes.

Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially are: Unilever’s global brands not meeting consumer preferences; Unilever’s ability to innovate and remain competitive; Unilever’s investment choices in its portfolio management; the effect of climate change on Unilever’s business; Unilever’s ability to find sustainable solutions to its plastic packaging; significant changes or deterioration in customer relationships; the recruitment and retention of talented employees; disruptions in our supply chain and distribution; increases or volatility in the cost of raw materials and commodities; the production of safe and high quality products; secure and reliable IT infrastructure; execution of acquisitions, divestitures and business transformation projects; economic, social and political risks and natural disasters; financial risks; failure to meet high and ethical standards; and managing regulatory, tax and legal matters. A number of these risks have increased as a result of the current Covid-19 pandemic.

These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

Further details of potential risks and uncertainties affecting the Group are described in the Group’s filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission, including in the Unilever Annual Report and Accounts 2021.


According to IQVIA Provoice survey for 12 months ending March 31, 2022.